Dr. Dallabrida recognized for driving innovation in patient-driven eData technologies that improve clinical research
Award-Winning PHT Corporation Scientist Dr. Susan Dallabrida to Present Poster on ePRO for Multiple Myeloma at ESMO 2014 Congress
For PHT Corporation
Brenda Nashawaty, 617-688-3253
PHT Corporation announced that Vice President of Clinical Science and Consulting Services Dr. Susan Dallabrida will present “Effective Use of Electronic Patient Reported Outcomes (ePRO) in Multiple Myeloma” at the ESMO 2014 Congress, 26-30 September in Madrid. PHT is the leading provider of technologies used to collect patient-driven eData for clinical research.
The ESMO 2014 Congress is sponsored by the European Society for Medical Oncology, the leading European professional organisation representing medical oncologists.
The poster abstract will also be published in the ESMO 2014 Congress Abstract Book, a supplement to the official ESMO journal Annals of Oncology.
The poster was developed by members of the PHT Clinical Science Team, with 100+ years of collective experience in ePROs and COAs:
Learn more about the PHT Clinical Science Team: http://bit.ly/PHTCSC
Learn about the Effective Use, Analysis, and Best [..] in a new educational webinar, 10 September. Register here: http://www.phtcorp.com/About/News-Events/Upcoming-.
About PHT Corporation
PHT Corporation is the eClinical innovator leading the adoption of patient-driven mobile apps for better clinical research. The PHT electronic clinical outcome assessment (eCOA) system collects and reports secure real-time patient data from the latest mobile devices. PHT scientific, regulatory and technological expertise combined with quality outcomes data enable clients to make research decisions with confidence. Sponsors and CROs have leveraged the PHT Patient Suite in 650+ trials resulting in 17+ regulatory approvals. Visit phtcorp.com for more information on PHT. Follow PHT on LinkedIn, Facebook, Twitter, Google+ and YouTube.
Disclaimer: If you have any questions regarding information in this press release please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims the content included in this release.